Source 1primary paper2025PPR
Toolkit/nano flow cytometry
nano flow cytometry
Also known as: nanoflow cytometry, nFCM
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Finally, we also demonstrated that nano flow cytometry is a powerful tool for assessing cell-free EV engineering efficiency.
Usefulness & Problems
Why this is useful
Nano flow cytometry is used here as a characterization technology to assess how efficiently HEK293 EVs were cell-free engineered.; assessing cell-free EV engineering efficiency; characterizing engineered extracellular vesicles
Source:
Nano flow cytometry is used here as a characterization technology to assess how efficiently HEK293 EVs were cell-free engineered.
Source:
assessing cell-free EV engineering efficiency
Source:
characterizing engineered extracellular vesicles
Problem solved
It gives the workflow a way to measure engineering efficiency for cell-free modified EVs.; provides an assay for evaluating efficiency of cell-free EV engineering
Source:
It gives the workflow a way to measure engineering efficiency for cell-free modified EVs.
Source:
provides an assay for evaluating efficiency of cell-free EV engineering
Problem links
provides an assay for evaluating efficiency of cell-free EV engineering
LiteratureIt gives the workflow a way to measure engineering efficiency for cell-free modified EVs.
Source:
It gives the workflow a way to measure engineering efficiency for cell-free modified EVs.
Published Workflows
Objective: Advance cell-free engineering of extracellular vesicles by manufacturing, isolating, characterizing, and then cell-free engineering HEK293 EVs with CD63-based membrane fusion proteins.
Why it works: The abstract states that cell-free gene expression systems can produce membrane proteins in vitro that can co-localise and integrate with exogenously added EVs, providing the mechanistic basis for the engineering workflow.
cell-free production of membrane proteins in vitroco-localization and integration of produced membrane proteins with exogenously added EVshollow fibre-based cell cultureEV isolationEV characterizationcell-free gene expressionnano flow cytometry
Stages
- 1.HEK293 EV biomanufacturing(library_build)
The abstract states that HEK293 EVs were manufactured before isolation, characterization, and cell-free engineering.
Selection: Generate HEK293 extracellular vesicles for downstream engineering.
- 2.EV isolation and characterization(secondary_characterization)
The abstract explicitly states that HEK293 EVs were isolated and characterised to advance cell-free EV engineering.
Selection: Prepare and characterize HEK293 EVs prior to cell-free engineering.
- 3.Cell-free engineering with CD63-based membrane fusion proteins(broad_screen)
The abstract reports that isolated HEK293 EVs were successfully cell-free engineered with several CD63-based membrane fusion proteins.
Selection: Test several CD63-based membrane fusion proteins on HEK293 EVs in a cell-free format.
- 4.Engineering efficiency assessment by nano flow cytometry(confirmatory_validation)
The abstract states that nano flow cytometry was demonstrated as a powerful tool for assessing cell-free EV engineering efficiency.
Selection: Assess cell-free EV engineering efficiency using nano flow cytometry.
Steps
- 1.Manufacture HEK293 extracellular vesicles
Generate HEK293 EV input material for the downstream cell-free engineering workflow.
Manufacturing must occur before EV isolation, characterization, and engineering because those later steps require EV material.
- 2.Isolate and characterize HEK293 extracellular vesicles
Prepare EVs and establish their characterized state before cell-free engineering.
Isolation and characterization are described before cell-free engineering, indicating that prepared EVs are needed as the substrate for the engineering step.
- 3.Cell-free engineer isolated HEK293 EVs with CD63-based membrane fusion proteinsengineered fusion membrane protein construct
Introduce CD63-based membrane fusion proteins onto exogenously added HEK293 EVs using a cell-free expression approach.
This step follows EV preparation because the cell-free produced membrane proteins are intended to co-localise and integrate with exogenously added EVs.
- 4.Assess cell-free EV engineering efficiency by nano flow cytometryassay method
Measure the efficiency of the cell-free EV engineering outcome.
Assessment occurs after engineering because the assay is used to evaluate the efficiency of the engineered EV product.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
No mechanism tags yet.
Techniques
Functional AssayTarget processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
It requires nano flow cytometry instrumentation and prepared EV samples from the engineering workflow.; requires access to nano flow cytometry instrumentation; requires engineered EV samples for analysis
The abstract does not indicate that nano flow cytometry measures EV functional potency or therapeutic efficacy.; the abstract does not provide specific benchmark metrics or comparison against alternative assays
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Nano flow cytometry is a powerful tool for assessing cell-free extracellular vesicle engineering efficiency.
Under the most optimal reported conditions, up to 4.83 × 10^11 per ml of HEK293 extracellular vesicles were successfully cell-free engineered with a CD63ITM3-mGL fusion membrane protein.
engineered HEK293 EV concentration 483000000000 /ml
Approval Evidence
1 source1 linked approval claimfirst-pass slug nano-flow-cytometry
Finally, we also demonstrated that nano flow cytometry is a powerful tool for assessing cell-free EV engineering efficiency.
Source:
assay utilitysupports
Nano flow cytometry is a powerful tool for assessing cell-free extracellular vesicle engineering efficiency.
Source:
Comparisons
Source-stated alternatives
The abstract mentions several characterization assays and technologies, but only nanoflow cytometry is explicitly named.
Source:
The abstract mentions several characterization assays and technologies, but only nanoflow cytometry is explicitly named.
Source-backed strengths
explicitly described as a powerful tool in this study
Source:
explicitly described as a powerful tool in this study
Compared with assays
The abstract mentions several characterization assays and technologies, but only nanoflow cytometry is explicitly named.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly described as a powerful tool in this study.
Relative tradeoffs: the abstract does not provide specific benchmark metrics or comparison against alternative assays.
Source:
The abstract mentions several characterization assays and technologies, but only nanoflow cytometry is explicitly named.
Ranked Citations
- 1.